Proteon Therapeutics Announces Publication of Results from Phase 3 PATENCY-1 Clinical Trial of Investigational Vonapanitase in Patients with Chronic Kidney Disease
January 24, 2019 08:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Jan. 24, 2019 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq: PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
Proteon Therapeutics to Present at the Stifel 2018 Healthcare Conference November 13th
November 08, 2018 07:45 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Proteon Therapeutics Announces Third Quarter 2018 Financial Results
November 07, 2018 08:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Proteon Therapeutics to Present at Two Upcoming Investor Conferences
August 29, 2018 08:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq: PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Proteon Therapeutics Announces Second Quarter 2018 Financial Results
August 07, 2018 08:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Physicians Dialysis Opens Frisco Facility in Texas
July 23, 2018 12:30 ET
|
Physicians Dialysis
MIAMI, July 23, 2018 (GLOBE NEWSWIRE) -- Physicians Dialysis is hosting an open house at their newest dialysis center located at 6116 Sports Village Road, Frisco, TX on Thursday July 26th from...
Proteon Therapeutics to Present at the JMP Securities Life Sciences Conference June 21st
June 14, 2018 08:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., June 14, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Proteon Therapeutics Announces First Quarter 2018 Financial Results
May 09, 2018 08:10 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., May 09, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...
Proteon Therapeutics and Lonza Extend Manufacturing Agreement for Commercial Supply
May 08, 2018 07:00 ET
|
Proteon Therapeutics, Inc.
Partners extend existing contract for manufacture of vonapanitase to 2029 as ongoing Phase 3 trial nears completionLonza Pharma & Biotech successfully scaled up a lab process at their Microbial...
Proteon Therapeutics Announces Fourth Quarter and Full-Year 2017 Financial Results
March 14, 2018 08:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., March 14, 2018 (GLOBE NEWSWIRE) -- Proteon Therapeutics, Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with...